High-risk Antithrombotic Drugs at Discharge and Consultation for Hemorrhagic or Thromboembolic Events in the Emergency Department

NCT07278648 · tracked via the Priya Life Science Spain tracker

Sponsor

Consorci Sanitari de l'Alt Penedès i Garraf

Phase

Observational

Started

2026-02-05

Last updated

2025-12-24

Condition(s) studied

Acute Disease

Investigational drug(s) / intervention(s)

Antithrombotic therapy

Antithrombotic therapy: Anticoagulant treatment prescribed at discharge from an acute care unit

Study summary

This observational study aims to estimate the proportion of patients discharged from a hospital with a prescription for anticoagulant medication who subsequently visit the emergency department due to an adverse thrombotic or hemorrhagic event related to the treatment.

Eligibility

Sex

ALL

Min age

18 Years

Max age

—

Healthy volunteers

Inclusion Criteria: * Patients discharged from the Emergency Department (ED) and acute care units with an electronic prescription for at least one anticoagulant medication (new or ongoing), identified with the following codes: B01AA - Vitamin K antagonists: warfarin and acenocoumarol B01AB - Heparin group: low-molecular weight heparins such as enoxaparin, tinzaparin, bemiparin, … B01AE - Direct thrombin inhibitors: dabigatran B01AF - Direct factor Xa inhibitors: rivaroxaban, apixaban, edoxaban Exclusion Criteria: * Those who are not part of the CSAPG healthcare area. * Patients discharged from outpatient clinics, home hospitalization units, intermediate care, or residential facilities.

Primary outcome measure(s)

Hemorragic event — Day 90 from baseline
Proportion of patients who experience a hemorrhagic event within 90 days of hospital discharge

Trial sites (1)

Facility	City	Region	Status
Hospital de Vilafranca	Vilafranca del Penedès	Barcelona

More Consorci Sanitari de l'Alt Penedès i Garraf trials in Spain

Impact of Humor Prescription on the Emotional Well-being of Patients With Medically Unexplained Symptoms: A Quasi-experimental Study Active, not recruiting

Predictive Model for Mortality in Older People With Critical Illness Recruiting

Tapping Test and the Archimedean Spiral for the Differential Diagnosis of Tremor. Machine Learning Approach Recruiting

Introducing Electronic Alerts to Reduce Inappropriate Digoxin Prescribing in Older Adults Starting soon

Is a Positive NECPAL in ICU Patients Associated With Higher Mortality Recruiting

Other trials for the same condition

Is a Positive NECPAL in ICU Patients Associated With Higher Mortality Recruiting

Levels of Diagnostic and Therapeutic Intervention in Hospitalized Patients Starting soon

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07278648 on ClinicalTrials.gov ↗ ← All trials in Spain